BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marti J, Giacca M, Alshebeeb K, Bahl S, Hua C, Horn JC, Bouayache J, Patel R, Facciuto M, Schwartz M, Florman S, Kim E, Gunasekaran G. Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center Experience. Journal of Vascular and Interventional Radiology 2018;29:920-6. [DOI: 10.1016/j.jvir.2018.01.780] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Chansangrat J, Keeratibharat N. Portal vein embolization: rationale, techniques, outcomes and novel strategies. Hepat Oncol 2021;8:HEP42. [PMID: 34765107 DOI: 10.2217/hep-2021-0006] [Reference Citation Analysis]
2 Charalel RA, Sung J, Askin G, Jo J, Mitry M, Chung C, Tmanova L, Madoff DC. Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients. Curr Oncol Rep 2021;23:135. [PMID: 34716800 DOI: 10.1007/s11912-021-01075-1] [Reference Citation Analysis]
3 Bekki Y, Marti J, Toshima T, Lewis S, Kamath A, Argiriadi P, Simpson W, Facciuto L, Patel RS, Gunasekaran G, Kim E, Schiano TD, Facciuto ME. A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. Surgery 2021;169:1044-51. [PMID: 33648768 DOI: 10.1016/j.surg.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Huang Y, Ge W, Kong Y, Ding Y, Gao B, Qian X, Wang W. Preoperative Portal Vein Embolization for Liver Resection: An updated meta-analysis. J Cancer 2021;12:1770-8. [PMID: 33613766 DOI: 10.7150/jca.50371] [Reference Citation Analysis]
5 Gunasekaran G, Bekki Y, Lourdusamy V, Schwartz M. Surgical Treatments of Hepatobiliary Cancers. Hepatology 2021;73 Suppl 1:128-36. [PMID: 32438491 DOI: 10.1002/hep.31325] [Cited by in Crossref: 29] [Cited by in F6Publishing: 40] [Article Influence: 29.0] [Reference Citation Analysis]
6 Tabori NE, Sivananthan G. Treatment Options for Early-Stage Hepatocellular Carcinoma. Semin Intervent Radiol 2020;37:448-55. [PMID: 33328700 DOI: 10.1055/s-0040-1720950] [Reference Citation Analysis]
7 Luz JHM, Bilhim T, Gomes FV, Costa NV, Coimbra E. Regarding: "Liver venous deprivation compared with portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: A single center experience". Surgery 2020;168:976-7. [PMID: 32307096 DOI: 10.1016/j.surg.2020.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Jiang MS, Luo XF, Wang Z, Li X. The transjugular approach is a safe and effective alternative for performing portal vein embolization. Medicine (Baltimore) 2019;98:e17851. [PMID: 31702644 DOI: 10.1097/MD.0000000000017851] [Reference Citation Analysis]
9 Gabr A, Polineni P, Mouli SK, Riaz A, Lewandowski RJ, Salem R. Neoadjuvant Radiation Lobectomy As an Alternative to Portal Vein Embolization in Hepatocellular Carcinoma. Semin Nucl Med 2019;49:197-203. [PMID: 30954185 DOI: 10.1053/j.semnuclmed.2019.01.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]